Financial Highlights
- Subscription revenue for the second quarter of fiscal 2014 was
$64.3 million , up 17% compared to$55.0 million in the prior year period - Client count for the second quarter of fiscal 2014 increased by six members bringing our total client network to 184 as of June 30, 2014
"It was another quarter of solid operating results for RPX," said
Summary Results
Revenue for the second quarter of fiscal 2014 was
Net acquisition spend during the quarter totaled
GAAP net income for the second quarter was
Non-GAAP net income for the second quarter, which excludes stock-based compensation and the amortization of acquired intangibles (in each case, net of tax), was
As of June 30, 2014, RPX had cash, cash equivalents and short-term investments of
Business Outlook
This outlook reflects the Company's current and preliminary view and may be subject to change. Please see the paragraph regarding "Forward-Looking Statements" at the end of this news release.
The Company provided the following business outlook for the third quarter of fiscal 2014:
Subscription revenue[2] |
| |
Fee-related revenue |
| |
Total revenue |
| |
Net income (non-GAAP) |
| |
Effective tax rate (non-GAAP) |
37% | |
Pro forma weighted-average diluted shares outstanding |
55.0 million |
The Company provided the following business outlook for the full year 2014:
Subscription revenue[2] |
| |
Fee-related revenue |
| |
Total revenue |
| |
Cost of revenue (non-GAAP) |
| |
SG&A (non-GAAP) |
| |
Net income (non-GAAP) |
| |
Effective tax rate (non-GAAP) |
37% | |
Pro forma weighted-average diluted shares outstanding |
54.6 million | |
Net acquisition spend |
|
The above outlook is forward-looking. Actual results may differ materially. Please refer to the information under the caption "Use of Non-GAAP Financial Information" below.
[1] Pro forma diluted shares computed to give effect to the shares of restricted stock outstanding as of the original date of issuance. | |||||||||||||||||||
[2] Subscription revenue is comprised of revenue generated from membership subscription services and premiums earned from insurance policies. |
Conference Call
RPX management will host a conference call and live webcast for analysts and investors at
RPX will offer a live webcast of the conference call which can be accessed from the "Investor Relations" section of the Company's website at http://ir.rpxcorp.com. An audio replay of the conference call will also be available approximately two hours after the call and will be available for 30 days. To hear the replay, parties in
About
Use of Non-GAAP Financial Information
This news release dated
To supplement the Company's condensed consolidated financial statements presented on a GAAP basis, management believes that these non-GAAP measures provide useful information about the Company's core operating results and thus are appropriate to enhance the overall understanding of the Company's past financial performance and its prospects for the future. Management is excluding from its non-GAAP operating results stock-based compensation expenses (inclusive of related employer payroll taxes), the amortization of acquired intangible assets (other than patents) and related tax effects. Management uses these non-GAAP measures to evaluate the Company's financial results, and believes these non-GAAP measures may prove useful to investors who wish to consider the impact of certain items when comparing the Company's financial performance with that of other companies. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors a more complete understanding of the Company's underlying operational results, trends and performance. The presentation of additional information should not be considered in isolation or as a substitute for or superior to financial results determined in accordance with GAAP.
Forward-Looking Statements
This news release and its attachments contain forward-looking statements within the meaning of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements regarding the future financial performance of RPX as well as any statements regarding the Company's strategic and operational plans. The Company's actual results may differ materially from those predicted or implied in these forward-looking statements. Factors that may contribute to such differences include, among others, the Company's ability to maintain an adequate rate of growth, the success of the Company's insurance business and other new initiatives, and the Company's ability to attract new clients and retain existing clients. Forward-looking statements are often identified by the use of words such as, but not limited to, "anticipate," "believe,"
"can," "continue," "could," "estimate," "expect," "intend," "may," "plan," "project," "seek," "should," "target," "will," "would," and similar expressions or variations intended to identify forward-looking statements. More information about potential factors that could affect the Company's business and financial results is included under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's most recent annual report on Form 10-K and its quarterly reports on Form 10-Q on file and available at the
| ||||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended | |||||||||||||||
2014 |
2013 |
2014 |
2013 | |||||||||||||
Revenue |
$ |
64,293 |
$ |
57,481 |
$ |
126,181 |
$ |
118,675 |
||||||||
Cost of revenue |
31,542 |
24,694 |
60,462 |
48,364 |
||||||||||||
Selling, general and administrative expenses |
18,579 |
15,736 |
35,834 |
30,209 |
||||||||||||
(Gain) loss on sale of patent assets, net |
(699) |
126 |
(699) |
126 |
||||||||||||
Operating income |
14,871 |
16,925 |
30,584 |
39,976 |
||||||||||||
Other income, net |
94 |
63 |
193 |
114 |
||||||||||||
Income before provision for income taxes |
14,965 |
16,988 |
30,777 |
40,090 |
||||||||||||
Provision for income taxes |
5,566 |
6,291 |
11,518 |
14,698 |
||||||||||||
Net income |
$ |
9,399 |
$ |
10,697 |
$ |
19,259 |
$ |
25,392 |
||||||||
Net income available to common stockholders: |
$ |
9,399 |
$ |
10,691 |
$ |
19,259 |
$ |
25,370 |
||||||||
Net income available to common stockholders per common share: |
||||||||||||||||
Basic |
$ |
0.18 |
$ |
0.21 |
$ |
0.36 |
$ |
0.49 |
||||||||
Diluted |
$ |
0.17 |
$ |
0.20 |
$ |
0.35 |
$ |
0.48 |
||||||||
Weighted-average shares used in computing net income available to common stockholders per common share: |
||||||||||||||||
Basic |
53,203 |
51,774 |
53,004 |
51,489 |
||||||||||||
Diluted |
54,776 |
53,463 |
54,622 |
53,055 |
| |||||||
Condensed Consolidated Balance Sheets | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
|
| ||||||
Assets |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
118,589 |
$ |
100,155 |
|||
Short-term investments |
198,965 |
190,567 |
|||||
Restricted cash |
583 |
364 |
|||||
Accounts receivable |
12,385 |
38,477 |
|||||
Prepaid expenses and other current assets |
13,776 |
10,546 |
|||||
Deferred tax assets |
4,082 |
3,817 |
|||||
Total current assets |
348,380 |
343,926 |
|||||
Patent assets, net |
235,501 |
219,954 |
|||||
Property and equipment, net |
4,391 |
4,667 |
|||||
Intangible assets, net |
4,441 |
1,718 |
|||||
Goodwill |
19,978 |
16,460 |
|||||
Restricted cash, less current portion |
1,091 |
1,454 |
|||||
Other assets |
584 |
622 |
|||||
Total assets |
$ |
614,366 |
$ |
588,801 |
|||
Liabilities and stockholders' equity |
|||||||
Current liabilities: |
|||||||
Accounts payable |
$ |
343 |
$ |
332 |
|||
Accrued liabilities |
8,442 |
8,784 |
|||||
Deferred revenue |
129,009 |
131,808 |
|||||
Deferred payment obligations |
— |
500 |
|||||
Other current liabilities |
4,418 |
1,638 |
|||||
Total current liabilities |
142,212 |
143,062 |
|||||
Deferred revenue, less current portion |
2,198 |
5,935 |
|||||
Deferred tax liabilities |
12,182 |
11,654 |
|||||
Other liabilities |
3,086 |
3,227 |
|||||
Total liabilities |
159,678 |
163,878 |
|||||
Stockholders' equity: |
|||||||
Common stock |
5 |
5 |
|||||
Additional paid-in capital |
315,868 |
305,343 |
|||||
Retained earnings |
138,786 |
119,527 |
|||||
Accumulated other comprehensive income |
29 |
48 |
|||||
Total stockholders' equity |
454,688 |
424,923 |
|||||
Total liabilities and stockholders' equity |
$ |
614,366 |
$ |
588,801 |
| |||||||
Condensed Consolidated Statements of Cash Flows | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
Six Months Ended | |||||||
2014 |
2013 | ||||||
Cash flows from operating activities |
|||||||
Net income |
$ |
19,259 |
$ |
25,392 |
|||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||
Depreciation and amortization |
59,289 |
47,798 |
|||||
Stock-based compensation |
8,868 |
8,186 |
|||||
Excess tax benefit from stock-based compensation |
(2,006) |
(2,009) |
|||||
(Gain) loss on sale of patent assets |
(699) |
126 |
|||||
Amortization of premium on investments |
3,380 |
2,995 |
|||||
Deferred taxes |
(978) |
(1,906) |
|||||
Other |
(500) |
13 |
|||||
Changes in assets and liabilities: |
|||||||
Accounts receivable |
26,414 |
216 |
|||||
Other receivables |
— |
33,775 |
|||||
Prepaid expenses and other assets |
(5,274) |
(3,348) |
|||||
Accounts payable |
11 |
130 |
|||||
Accrued and other liabilities |
(823) |
(1,191) |
|||||
Deferred revenue |
(6,636) |
13,202 |
|||||
Net cash provided by operating activities |
100,305 |
123,379 |
|||||
Cash flows from investing activities |
|||||||
Purchases of investments classified as available-for-sale |
(106,618) |
(98,950) |
|||||
Maturities of investments classified as available-for-sale |
98,920 |
65,787 |
|||||
Sales of investments classified as available-for-sale |
— |
1,099 |
|||||
Business acquisition, net of cash |
(2,169) |
— |
|||||
Decrease in restricted cash |
144 |
— |
|||||
Purchases of property and equipment |
(790) |
(874) |
|||||
Acquisitions of patent assets |
(73,948) |
(69,637) |
|||||
Proceeds from sale of patent assets |
860 |
100 |
|||||
Net cash used in investing activities |
(83,601) |
(102,475) |
|||||
Cash flows from financing activities |
|||||||
Proceeds from exercise of stock options and other common stock issuances |
2,399 |
2,727 |
|||||
Tax withholdings related to net share settlements of restricted stock units |
(2,675) |
— |
|||||
Excess tax benefit from stock-based compensation |
2,006 |
2,009 |
|||||
Net cash provided by financing activities |
1,730 |
4,736 |
|||||
Net increase in cash and cash equivalents |
18,434 |
25,640 |
|||||
Cash and cash equivalents at beginning of period |
100,155 |
73,638 |
|||||
Cash and cash equivalents at end of period |
$ |
118,589 |
$ |
99,278 |
| ||||||||||||||||
Reconciliation of Pro Forma Net Income Per Share | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended | |||||||||||||||
2014 |
2013 |
2014 |
2013 | |||||||||||||
Net income |
$ |
9,399 |
$ |
10,697 |
$ |
19,259 |
$ |
25,392 |
||||||||
Pro forma net income per share: |
||||||||||||||||
Basic |
$ |
0.18 |
$ |
0.21 |
$ |
0.36 |
$ |
0.49 |
||||||||
Diluted |
$ |
0.17 |
$ |
0.20 |
$ |
0.35 |
$ |
0.48 |
||||||||
Shares used in computing pro forma net income per share: |
||||||||||||||||
Basic: |
||||||||||||||||
Basic weighted-average common shares |
53,203 |
51,774 |
53,004 |
51,489 |
||||||||||||
Add: Restricted stock |
— |
31 |
— |
45 |
||||||||||||
Shares used in computing pro forma basic net income per share |
53,203 |
51,805 |
53,004 |
51,534 |
||||||||||||
Diluted: |
||||||||||||||||
Diluted weighted-average common shares |
54,776 |
53,463 |
54,622 |
53,055 |
||||||||||||
Add: Restricted stock |
— |
31 |
— |
45 |
||||||||||||
Shares used in computing pro forma diluted net income per share |
54,776 |
53,494 |
54,622 |
53,100 |
| ||||||||||||||||
Reconciliation of GAAP to Pro Forma Non-GAAP Net Income Per Share | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended | |||||||||||||||
2014 |
2013 |
2014 |
2013 | |||||||||||||
Net income |
$ |
9,399 |
$ |
10,697 |
$ |
19,259 |
$ |
25,392 |
||||||||
Stock-based compensation[1] |
5,162 |
4,658 |
9,081 |
8,436 |
||||||||||||
Amortization of acquired intangible assets[2] |
257 |
358 |
562 |
718 |
||||||||||||
Income tax adjustments[3] |
(1,873) |
(1,676) |
(3,242) |
(2,961) |
||||||||||||
Non-GAAP net income |
$ |
12,945 |
$ |
14,037 |
$ |
25,660 |
$ |
31,585 |
||||||||
Pro forma non-GAAP net income per share: |
||||||||||||||||
Basic |
$ |
0.24 |
$ |
0.27 |
$ |
0.48 |
$ |
0.61 |
||||||||
Diluted |
$ |
0.24 |
$ |
0.26 |
$ |
0.47 |
$ |
0.59 |
||||||||
Shares used in computing pro forma net income per share: |
||||||||||||||||
Basic |
53,203 |
51,805 |
53,004 |
51,534 |
||||||||||||
Diluted |
54,776 |
53,494 |
54,622 |
53,100 |
| ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Cost of Revenue | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended | |||||||||||||||
2014 |
2013 |
2014 |
2013 | |||||||||||||
Cost of revenue |
$ |
31,542 |
$ |
24,694 |
$ |
60,462 |
$ |
48,364 |
||||||||
Amortization of acquired intangible assets[2] |
(47) |
(56) |
(103) |
(112) |
||||||||||||
Non-GAAP cost of revenue |
$ |
31,495 |
$ |
24,638 |
$ |
60,359 |
$ |
48,252 |
| ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Selling, General and Administrative Expenses | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended | |||||||||||||||
2014 |
2013 |
2014 |
2013 | |||||||||||||
Selling, general and administrative expenses |
$ |
18,579 |
$ |
15,736 |
$ |
35,834 |
$ |
30,209 |
||||||||
Stock-based compensation[1] |
(5,162) |
(4,658) |
(9,081) |
(8,436) |
||||||||||||
Amortization of acquired intangible assets[2] |
(210) |
(302) |
(459) |
(606) |
||||||||||||
Non-GAAP selling, general and administrative expenses |
$ |
13,207 |
$ |
10,776 |
$ |
26,294 |
$ |
21,167 |
| ||||||||
Additional Metrics | ||||||||
(in thousands, except client and headcount data) | ||||||||
(unaudited) | ||||||||
As of and for the Three Months Ended | ||||||||
Operating Metrics |
2014 |
2013 | ||||||
Number of clients |
184 |
157 |
||||||
Net additions |
6 |
11 |
||||||
Trailing four quarters |
27 |
37 |
||||||
Gross acquisition spend |
$ |
18,795 |
$ |
41,100 |
||||
Trailing four quarters |
$ |
139,162 |
$ |
201,273 |
||||
Net acquisition spend |
$ |
17,795 |
$ |
39,100 |
||||
Trailing four quarters |
$ |
131,412 |
$ |
118,073 |
||||
Full time equivalent headcount |
138 |
123 |
||||||
As of and for the Three Months Ended | ||||||||
Financial Metrics |
2014 |
2013 | ||||||
Subscription revenue[4] |
$ |
64,293 |
$ |
54,979 |
||||
Fee-related revenue |
— |
2,502 |
||||||
Total revenue |
$ |
64,293 |
$ |
57,481 |
||||
Cash, cash equivalents and short-term investments |
$ |
317,554 |
$ |
259,305 |
||||
Deferred revenue, current and noncurrent |
$ |
131,207 |
$ |
117,573 |
[1] |
RPX excludes stock-based compensation and related employer payroll taxes from its non-GAAP financial measures. |
[2] |
RPX excludes amortization expense related to intangible assets (other than patents) acquired in conjunction with the acquisition of businesses from its non-GAAP financial measures. |
[3] |
Amount reflects income taxes associated with the above noted non-GAAP exclusions. |
[4] |
Subscription revenue is comprised of revenue generated from membership subscription services and premiums earned from insurance policies. |
Logo - http://photos.prnewswire.com/prnh/20130730/SF55756LOGO
SOURCE
News Provided by Acquire Media